Leveraging European infrastructures to access 1 million human genomes by 2022.


Journal

Nature reviews. Genetics
ISSN: 1471-0064
Titre abrégé: Nat Rev Genet
Pays: England
ID NLM: 100962779

Informations de publication

Date de publication:
11 2019
Historique:
accepted: 03 07 2019
pubmed: 29 8 2019
medline: 4 3 2020
entrez: 29 8 2019
Statut: ppublish

Résumé

Human genomics is undergoing a step change from being a predominantly research-driven activity to one driven through health care as many countries in Europe now have nascent precision medicine programmes. To maximize the value of the genomic data generated, these data will need to be shared between institutions and across countries. In recognition of this challenge, 21 European countries recently signed a declaration to transnationally share data on at least 1 million human genomes by 2022. In this Roadmap, we identify the challenges of data sharing across borders and demonstrate that European research infrastructures are well-positioned to support the rapid implementation of widespread genomic data access.

Identifiants

pubmed: 31455890
doi: 10.1038/s41576-019-0156-9
pii: 10.1038/s41576-019-0156-9
pmc: PMC7115898
mid: EMS88057
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

693-701

Subventions

Organisme : Wellcome Trust
ID : 201535
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 201535/Z/16/Z
Pays : United Kingdom

Commentaires et corrections

Type : ErratumIn

Références

Eur J Hum Genet. 2018 Jun;26(6):778-785
pubmed: 29487416
Eur J Hum Genet. 2018 Feb;26(2):149-156
pubmed: 29187736
Ann Intern Med. 2019 Mar 5;170(5):332-334
pubmed: 30776795
F1000Res. 2016 Sep 30;5:
pubmed: 27803796
Hum Mutat. 2015 Oct;36(10):915-21
pubmed: 26295439
Biopreserv Biobank. 2016 Dec;14(6):559-562
pubmed: 27936342
Nat Genet. 2015 Jul;47(7):692-5
pubmed: 26111507
F1000Res. 2018 Aug 6;7:
pubmed: 30254736
Biopreserv Biobank. 2018 Jun;16(3):233-241
pubmed: 29781706
Biopreserv Biobank. 2016 Aug;14(4):298-306
pubmed: 26977825
Nat Biotechnol. 2019 Mar;37(3):220-224
pubmed: 30833764
Nature. 2017 Oct 18;550(7677):451-453
pubmed: 29072289
Biopreserv Biobank. 2018 Dec;16(6):458-462
pubmed: 30102551
J Am Med Inform Assoc. 2015 Nov;22(6):1143-7
pubmed: 26174866
Genome Med. 2016 Jun 23;8(1):71
pubmed: 27338147

Auteurs

Gary Saunders (G)

ELIXIR Hub, Wellcome Genome Campus, Hinxton, Cambridge, UK.

Michael Baudis (M)

University of Zurich, Zurich, Switzerland.

Regina Becker (R)

Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Luxembourg, Luxembourg.

Sergi Beltran (S)

CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.

Christophe Béroud (C)

Aix Marseille Univ, INSERM, MMG, Marseille, France.
Département de Génétique Médicale et de Biologie Cellulaire, APHM, Hôpital d'Enfants de la Timone, Marseille, France.

Ewan Birney (E)

European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.

Cath Brooksbank (C)

European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.

Søren Brunak (S)

Department of Health Technology, Technical University of Denmark, Lyngby, Denmark.
Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark.

Marc Van den Bulcke (M)

Cancer Centre, Epidemiology and Public Health, Sciensano, Ixelles, Belgium.

Rachel Drysdale (R)

ELIXIR Hub, Wellcome Genome Campus, Hinxton, Cambridge, UK.

Salvador Capella-Gutierrez (S)

Barcelona Supercomputing Centre (BSC), Barcelona, Spain.

Paul Flicek (P)

European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.

Francesco Florindi (F)

BBMRI-ERIC, Graz, Austria.

Peter Goodhand (P)

Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
Global Alliance for Genomics and Health, Toronto, Ontario, Canada.

Ivo Gut (I)

CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.

Jaap Heringa (J)

Department of Computer Science, Vrije Universiteit, Amsterdam, Netherlands.

Petr Holub (P)

BBMRI-ERIC, Graz, Austria.

Jef Hooyberghs (J)

Flemish Institute for Technological Research, VITO, Mol, Belgium.

Nick Juty (N)

School of Computer Science, The University of Manchester, Manchester, UK.

Thomas M Keane (TM)

European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.

Jan O Korbel (JO)

European Molecular Biology Laboratory, Genome Biology Unit, Heidelberg, Germany.

Ilkka Lappalainen (I)

CSC - IT Center for Science, Espoo, Finland.

Brane Leskosek (B)

IBMI, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.

Gert Matthijs (G)

Katholieke Universiteit Leuven, Leuven, Belgium.

Andres Metspalu (A)

Estonian Genome Center, University of Tartu, Tartu, Estonia.

Arcadi Navarro (A)

Institute of Evolutionary Biology (UPF-CSIC), Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain.
Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.
Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.

Steven Newhouse (S)

European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.

Tommi Nyrönen (T)

CSC - IT Center for Science, Espoo, Finland.

Angela Page (A)

Global Alliance for Genomics and Health, Toronto, Ontario, Canada.
Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Bengt Persson (B)

Department of Cell and Molecular Biology, Science for Life Laboratory, Uppsala, Sweden.

Aarno Palotie (A)

Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.

Helen Parkinson (H)

European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.

Jordi Rambla (J)

Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.

David Salgado (D)

Aix Marseille Univ, INSERM, MMG, Marseille, France.

Erik Steinfelder (E)

BBMRI-ERIC, Graz, Austria.

Morris A Swertz (MA)

BBMRI-NL/University Medical Center Groningen, University of Groningen, Groningen, Netherlands.

Alfonso Valencia (A)

Barcelona Supercomputing Centre (BSC), Barcelona, Spain.
ICREA, Pg., Barcelona, Spain.

Susheel Varma (S)

European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.

Niklas Blomberg (N)

ELIXIR Hub, Wellcome Genome Campus, Hinxton, Cambridge, UK.

Serena Scollen (S)

ELIXIR Hub, Wellcome Genome Campus, Hinxton, Cambridge, UK. serena.scollen@elixir-europe.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH